MedTrace Logo

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

NCT01515228 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2015-01-09

No results posted yet for this study

Summary

The purpose of this study is to examine the safety and effectiveness of coronary stenting with the Cilotax stent compared to the Xience Prime stent in the treatment of diabetic patients.

Conditions

Interventions

DEVICE

Xience Prime

everolimus-eluting stent implantation

DEVICE

Cilotax stent

paclitaxel with cilostazol dual drug eluting stent implantation

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • CHEOL WHAN LEE, MD, PhD.

    lead OTHER

Principal Investigators

  • Cheol-Whan Lee, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01515228 on ClinicalTrials.gov